Crispr Therapeutics shares owned by Zeke Capital Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Zeke Capital Advisors
from 13F filings
Historical chart of Zeke Capital Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Zeke Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Zeke Capital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2022-12-31 | $1.3M | 31k | 40.65 |
2022-09-30 | $2.3M | 35k | 65.34 |
2022-06-30 | $2.1M | 35k | 60.75 |
2022-03-31 | $1.9M | 30k | 62.69 |
2021-12-31 | $1.8M | 24k | 75.79 |
2021-09-30 | $1.5M | 13k | 111.97 |
2021-06-30 | $2.2M | 14k | 161.92 |